SILVIA
LÓPEZ FERNÁNDEZ
DOCENTE INVITADA
Publicaciones (32) Publicaciones de SILVIA LÓPEZ FERNÁNDEZ
2024
-
Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis
Revista Espanola de Cardiologia
-
Giant intramyocardial mass: a rare cause of bifascicular block
European heart journal. Cardiovascular Imaging, Vol. 25, Núm. 3, pp. e112
2023
-
Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881
-
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
Clinical Research in Cardiology
-
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204
2022
-
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078
-
Gender differences in drug titration among heart failure patients with reduced ejection fraction in the ETIFIC trial
Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 636-648
-
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics
Journal of Clinical Medicine, Vol. 11, Núm. 5
-
Técnicas de imagen no invasiva en cardiología
Bases de la medicina interna. Fisiopatología y propedéutica médica: Volumen II (Avicam), pp. 141-166
2021
-
Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study
ESC Heart Failure, Vol. 8, Núm. 6, pp. 4820-4831
-
Layer-Specific Global Longitudinal Strain Predicts Arrhythmic Risk in Arrhythmogenic Cardiomyopathy
Frontiers in Cardiovascular Medicine, Vol. 8
2020
-
Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323
-
Myocardial fibrosis in arrhythmogenic cardiomyopathy: A genotype-phenotype correlation study
European Heart Journal Cardiovascular Imaging, Vol. 21, Núm. 4, pp. 378-386
-
One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
-
Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
2019
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
2018
-
Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia
Circulation, Vol. 137, Núm. 15, pp. 1595-1610
-
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462
-
Prognostic value of nocturnal pulse oximetry in patients with heart failure
Medicina Clinica, Vol. 150, Núm. 10, pp. 383-386
2017
-
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 19, Núm. 10, pp. 1242-1254